Get started
Author

Simone Bernardi

Observed names: Bernardi Simone, S. Bernardi, Simone BERNARDI
ORCID: 0009-0002-5071-3167
Observed ORCID: 0009-0002-5071-3167
OpenAlex ID: A5091339382
Body weight, gender and response to TNF- blockers in axial spondyloarthritis
2014 · E. Gremese, S. Bernardi, et al. · Rheumatology · 129
Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment
2013 · L. Santoro, F. D'Onofrio, et al. · Rheumatology · 31
A New Case of DRESS Syndrome Induced by Sulfasalazine and Triggered by Amoxicillin
2013 · Francesco Girelli, Simone Bernardi, et al. · Case Reports in Rheumatology · 30
PDF
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study
2023 · Marino Paroli, Andrea Becciolini, et al. · Medicina · 16
PDF
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy
2024 · Marino Paroli, Andrea Becciolini, et al. · Journal of Clinical Medicine · 14
PDF
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
2024 · Simone Parisi, Becciolini Andrea, et al. · Current Research in Pharmacology and Drug Discovery · 10
PDF
Thrombocytosis in systemic lupus erythematosus: a possible clue to autosplenectomy?
2007 · Gabriella Castellino, Marcello Govoni, et al. · PubMed · 10
PDF
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study
2024 · Marta Priora, Andrea Becciolini, et al. · Medicina · 9
PDF
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study
2023 · Alberto Lo Gullo, Andrea Becciolini, et al. · Journal of Clinical Medicine · 7
PDF
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study
2023 · Andrea Becciolini, Simone Parisi, et al. · Biomedicines · 6
PDF
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study
2025 · Camilla Mazzanti, Marino Paroli, et al. · Journal of Psoriasis and Psoriatic Arthritis · 4
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
2025 · Andrea Becciolini, Antonio Marchesoni, et al. · Rheumatology Advances in Practice · 4
PDF
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis
2024 · Alberto LO GULLO, Simone PARISI, et al. · Minerva Medica · 4
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort
2025 · Eleonora Celletti, Myriam Di Penta, et al. · Rheumatology and Therapy · 2
PDF
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter study
2025 · Alarico Ariani, Maddalena Larosa, et al. · BMC Rheumatology · 2
PDF
Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature.
2023 · Luca Magnani, Alarico Ariani, et al. · Acta bio-medica dell'Ateneo parmense/Acta biomedica · 2
PDF
Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study
2026 · Alessandro Conforti, Alarico Ariani, et al. · Scientific Reports · 1
PDF
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis
2026 · Valentino Paci, Alarico Ariani, et al. · Rheumatology and Therapy · 1
PDF
Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort
2026 · Alessandro Conforti, Martina Gentile, et al. · Frontiers in Medicine
PDF
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al
2026 · Camilla Mazzanti, Marino Paroli, et al. · Journal of Psoriasis and Psoriatic Arthritis
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study
2026 · Daniele Lini, Matteo Colina, et al. · Mediterranean Journal of Rheumatology
PDF
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study
2026 · Simone Parisi, Andrea Becciolini, et al. · Therapeutic Advances in Musculoskeletal Disease
ABS0436 APREMILAST VS ADALIMUMAB EFFECTIVENESS IN BIOLOGIC-NAIVE PsA
2025 · C. Castellani, O. Addimanda, et al. · Annals of the Rheumatic Diseases
Abs0668 Multicenter Observational Study on the Efficacy of Guselkumab in Psoriatic Arthritis
2025 · A. Lo Gullo, S. Parisi, et al. · Annals of the Rheumatic Diseases
Retention rate of upadacitinib therapy in rheumatoid arthritis: Results of a large Italian multicenter real-world study
2024 · Palma Scolieri, Andrea Becciolini, et al. · Rheumatology (Bulgaria)
PDF
Works count: 37
Citation count: 282
H-index: 8
I10-index: 7
Year
Topic
Type